Haleon plc (NYSE:HLN) Shares Acquired by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. increased its position in shares of Haleon plc (NYSE:HLN) by 6.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,868 shares of the company’s stock after acquiring an additional 2,758 shares during the period. Atria Wealth Solutions Inc.’s holdings in Haleon were worth $457,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Synovus Financial Corp increased its position in Haleon by 0.8% in the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after purchasing an additional 1,216 shares during the last quarter. Greenleaf Trust increased its stake in shares of Haleon by 8.4% in the fourth quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after purchasing an additional 1,333 shares during the period. Baron Wealth Management LLC lifted its position in shares of Haleon by 4.3% during the 4th quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock worth $321,000 after purchasing an additional 1,381 shares during the last quarter. Peapack Gladstone Financial Corp boosted its stake in Haleon by 3.2% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock valued at $474,000 after purchasing an additional 1,390 shares during the period. Finally, CENTRAL TRUST Co grew its holdings in Haleon by 19.1% in the 4th quarter. CENTRAL TRUST Co now owns 8,932 shares of the company’s stock valued at $85,000 after buying an additional 1,430 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Down 3.9 %

Shares of HLN opened at $9.81 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The stock has a market capitalization of $44.39 billion, a PE ratio of 28.84, a P/E/G ratio of 2.82 and a beta of 0.28. The firm’s 50 day moving average is $9.59 and its 200-day moving average is $9.83.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Equities research analysts forecast that Haleon plc will post 0.43 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on HLN shares. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein downgraded shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Haleon currently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.